Synergy Innovation Co., Ltd. (KOSDAQ: 048870)
South Korea
· Delayed Price · Currency is KRW | Market Cap | 207.60B |
| Revenue (ttm) | 94.58B |
| Net Income (ttm) | 6.26B |
| Shares Out | 82.71M |
| EPS (ttm) | 75.22 |
| PE Ratio | 33.37 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 591,350 |
| Open | 2,525.00 |
| Previous Close | 2,525.00 |
| Day's Range | 2,405.00 - 2,555.00 |
| 52-Week Range | 2,100.00 - 3,870.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2024 |
About Synergy Innovation
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. ... [Read more]
Financial Performance
In 2023, Synergy Innovation's revenue was 83.21 billion, a decrease of -3.84% compared to the previous year's 86.54 billion. Earnings were 2.30 billion, a decrease of -85.71%.
Financial StatementsNews
Tony Stark's Choice Vape? Synergy Innovation's Strategic Move To Restore Brands' Identity, Lead Market Niche
Synergy Innovation , recently launched as a house of brands, is making waves in the cannabis accessories sector with its acquisition of DaVinci and Eyce . This new venture marks a significant return t...